Literature DB >> 13627765

Preliminary clinical trial of p-di-2-chloroethyl-amino-L-phenylalanine (CB 3025, melphalan) and of di-2-chloroethyl methanesulfonate (CB 1506).

R PAPAC, D A GALTON, M TILL, E WILTSHAW.   

Abstract

Entities:  

Keywords:  CYTOTOXIC DRUGS/therapeutic use; NITROGEN MUSTARDS/therapeutic use

Mesh：

Substances：

Year:  1958        PMID： 13627765     DOI： 10.1111/j.1749-6632.1958.tb42674.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  5 in total

1.  Chemotherapy of cancer.

Authors:  K A NEWTON
Journal:  Postgrad Med J       Date:  1958-12       Impact factor: 2.401

2.  Biochemical studies with methanesulphonyl esters, especially beta-chloroethyl methanesulphonate.

Authors:  D E Briggs
Journal:  Biochem J       Date:  1960-10       Impact factor: 3.857

3.  Population Pharmacokinetics of Melphalan in a Large Cohort of Autologous and Allogeneic Hematopoietic Cell Transplantation Recipients: Towards Individualized Dosing Regimens.

Authors:  Gunjan L Shah; Jaap Jan Boelens; Dean Carlow; Andrew Lin; Ryan Schofield; Nancy Cruz Sitner; Anna Alperovich; Josel Ruiz; Anthony Proli; Parastoo Dahi; Roni Tamari; Sergio A Giralt; Michael Scordo; Rick Admiraal
Journal:  Clin Pharmacokinet       Date:  2021-12-02       Impact factor: 5.577

Review 4.  Cancer chemotherapy: past, present, and future--Part I.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1984-08       Impact factor: 1.798

5.  ORAL MELPHALAN THERAPY IN ADVANCED MALIGNANT DISEASE.

Authors:  P CLIFFORD; R A CLIFT; J H GILLMORE
Journal:  Br J Cancer       Date:  1963-09       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.